Objective:

To highlight the efficacy and benefits of orthokeratology (ortho-k) in slowing myopia progression in children and teenagers.

Approach:

Key Findings:

• Ortho-k slows axial elongation and vitreous chamber depth by approximately 50%.
• The greatest benefit is observed in children aged 6 to 8 years.
• Ortho-k is effective in managing myopia with moderate to high astigmatism.
• It can also address anisometropia effectively.
• Combination treatment with atropine shows enhanced efficacy.

Interpretation:

Ortho-k is a robust option for myopia management, offering significant benefits in slowing progression and improving quality of life for children.

Limitations:

• The adaptation effects of treatment may limit long-term efficacy.
• The majority of safety data is derived from adult studies.

Conclusion:

Ortho-k remains a vital tool in myopia management, with a strong evidence base and the ability to tailor treatment to individual needs.

Sources:

• Cho et al, 2005
• Sun et al, 2015
• Cho and Cheung, 2017
• Chen et al, 2013
• Charm and Cho, 2013
• Tsai et al, 2021
• Tsai et al, 2022
• Guo et al, 2023
• Santodomingo-Rubido et al, 2013
• Yang et al, 2021
• Bullimore et al, 2021
• Stapleton et al, 2008
• Chua et al, 2006
• Sankaridurg et al, 2023
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.